CRANIAL NERVE FUNCTION ABNORMALITY DETECTION AGENT

• Main Authors: OBA HIROYUKI, TSUKADA HIDEO, HASHIMOTO FUMIO
• Format: Patent
• Language: English; Japanese
• Published: 01.08.2019
• Subjects: HUMAN NECESSITIES; HYGIENE; MEDICAL OR VETERINARY SCIENCE; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

To provide a cranial nerve function abnormality detection agent which can detect cranial nerve function abnormality at an early stage.SOLUTION: Provided is a cranial nerve function abnormality detection agent containing a compound represented by a general formula (1) as an active ingredient and being based on the detection of olfactory nerve mitochondrial complex I (MC-I). [In the general formula (1), R represents -O(CH)-, -O(CH)OCH-, -CHO(CH)-, or -CHO(CH)OCH-; n represents an integer of 1-5; and Qrepresents a label group.]SELECTED DRAWING: None 【課題】脳神経機能異常を早期に検出することができる脳神経機能異常検出剤を提供すること。【解決手段】一般式（１）で表される化合物を有効成分として含有し、嗅覚神経のミトコンドリアコンプレックス−Ｉ（ＭＣ−Ｉ）の検出に基づく、脳神経機能異常検出剤。［一般式（１）中、Ｒは、−Ｏ（ＣＨ２）ｎ−、−Ｏ（ＣＨ２）ｎＯＣ２Ｈ４−、−ＣＨ２Ｏ（ＣＨ２）ｎ−又は−ＣＨ２Ｏ（ＣＨ２）ｎＯＣ２Ｈ４−を示し、ｎは１〜５の整数を示し、Ｑ１は、標識基を示す。］【選択図】なし